Treatment of multiple sclerosis with mitoxantrone

  title={Treatment of multiple sclerosis with mitoxantrone},
  author={Erich Mauch and Hans Helmut Kornhuber and Hilmar Krapf and U. Fetzer and H. Laufen},
  journal={European Archives of Psychiatry and Clinical Neuroscience},
Ten multiple sclerosis patients, all with a rapid deteriorating disease profile, were treated with 12 mg/m2 of the cytostatic agent mitoxantrone, administered every 3 months. This dosage is only 25% of what a patient with a solid tumour would normally receive during the same time period. In all treated patients the deterioration was stopped following the… CONTINUE READING